138 related articles for article (PubMed ID: 8854045)
1. Synthesis and evaluation as platelet aggregation inhibitors of 6-phenyl-2,4-substituted-3(2H)-pyridazinones and their rigid analogues benzo[h]cinnolin-3,5-diones.
Dal Piaz V; Ciciani G; Giovannoni MP
Drug Des Discov; 1996 Mar; 14(1):53-75. PubMed ID: 8854045
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 4,5-functionalized-2-methyl-6-(substituted aryl)-3 (2H)-pyridazinones: a new group of potent platelet aggregation inhibitors.
Dal Piaz V; Ciciani G; Giovannoni MP
Farmaco; 1997 Mar; 52(3):173-8. PubMed ID: 9212451
[TBL] [Abstract][Full Text] [Related]
3. [Synthesis and platelet aggregation inhibitory activity of 6-(4-substituted phenyl)-4,5-dihydro-3(2H)-pyridazinones].
Jiang Q; Sun CS
Yao Xue Xue Bao; 1990; 25(8):598-603. PubMed ID: 2082682
[TBL] [Abstract][Full Text] [Related]
4. [Synthesis and platelet aggregation inhibitory activity of 6-substituted dihydropyridazinones].
Yao FM; Sun CS
Yao Xue Xue Bao; 1993; 28(7):548-52. PubMed ID: 8285059
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and structure-activity relationships of a novel series of 5-alkylidenepyridazin-3(2H)-ones with a non-cAMP-based antiplatelet activity.
Coelho A; Raviña E; Fraiz N; Yáñez M; Laguna R; Cano E; Sotelo E
J Med Chem; 2007 Dec; 50(26):6476-84. PubMed ID: 18031002
[TBL] [Abstract][Full Text] [Related]
6. 2-Substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors: design, synthesis, and SAR studies.
Meyers C; Yáñez M; Elmaatougi A; Verhelst T; Coelho A; Fraiz N; Lemière GL; García-Mera X; Laguna R; Cano E; Maes BU; Sotelo E
Bioorg Med Chem Lett; 2008 Jan; 18(2):793-7. PubMed ID: 18053717
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new 4,5-3(2H)pyridazinone derivatives and their cardiotonic, hypotensive, and platelet aggregation inhibition activities.
Amin EN; Abdel-Alim AA; Abdel-Moty SG; El-Shorbagi AN; Abdel-Rahman MSh
Arch Pharm Res; 2010 Jan; 33(1):25-46. PubMed ID: 20191341
[TBL] [Abstract][Full Text] [Related]
8. Pyridazines. Part XXIX: synthesis and platelet aggregation inhibition activity of 5-substituted-6-phenyl-3(2H)-pyridazinones. Novel aspects of their biological actions.
Sotelo E; Fraiz N; Yáñez M; Terrades V; Laguna R; Cano E; Raviña E
Bioorg Med Chem; 2002 Sep; 10(9):2873-82. PubMed ID: 12110307
[TBL] [Abstract][Full Text] [Related]
9. Chiral resolution and absolute configuration of the enantiomers of 5-acetyl-2-methyl-4-methylsulfinyl-6-phenyl-3(2H)-pyridazinone and evaluation of their platelet aggregation inhibitory activity.
Azzolina O; Dal Piaz V; Collina S; Giovannoni MP; Tadini C
Chirality; 1997; 9(7):681-5. PubMed ID: 9366028
[TBL] [Abstract][Full Text] [Related]
10. Pyridazines. XIII. Synthesis of 6-aryl-5-oxygenated substituted-3(2H)-pyridazinones and evaluation as platelet aggregation inhibitors.
Laguna R; Rodriguez-Liñares B; Cano E; Estevez I; Raviña E; Sotelo E
Chem Pharm Bull (Tokyo); 1997 Jul; 45(7):1151-5. PubMed ID: 9246748
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and pharmacological evaluation of 4,4a,5,6-tetrahydro-7,8-disubstituted-benzo[h]cinnolin-3(2H)-ones.
Pinna GA; Loriga M; Curzu MM; D'Amico M
Farmaco; 1997 Jan; 52(1):25-8. PubMed ID: 9181677
[TBL] [Abstract][Full Text] [Related]
12. Pyridazines. Part 31: synthesis and antiplatelet activity of 4,5-disubstituted-6-phenyl-3(2H)-pyridazinones.
Sotelo E; Fraiz N; Yáñez M; Laguna R; Cano E; Raviña E
Chem Pharm Bull (Tokyo); 2002 Dec; 50(12):1574-7. PubMed ID: 12499593
[TBL] [Abstract][Full Text] [Related]
13. Pyridazines part 41: synthesis, antiplatelet activity and SAR of 2,4,6-substituted 5-(3-oxo-3-phenylprop-1-en-1-yl)- or 5-(3-phenylprop-2-enoyl)pyridazin-3(2H)-ones.
Crespo A; Meyers C; Coelho A; Yáñez M; Fraiz N; Sotelo E; Maes BU; Laguna R; Cano E; Lemière GL; Raviña E
Bioorg Med Chem Lett; 2006 Feb; 16(4):1080-3. PubMed ID: 16290144
[TBL] [Abstract][Full Text] [Related]
14. Pyridazines. Part 36: Synthesis and antiplatelet activity of 5-substituted-6-phenyl-3(2H)-pyridazinones.
Coelho A; Sotelo E; Fraiz N; Yáñez M; Laguna R; Cano E; Raviña E
Bioorg Med Chem Lett; 2004 Jan; 14(2):321-4. PubMed ID: 14698150
[TBL] [Abstract][Full Text] [Related]
15. Pyridazines. Part 28: 5-alkylidene-6-phenyl-3(2H)-pyridazinones, a new family of platelet aggregation inhibitors.
Sotelo E; Fraiz N; Yáñez M; Laguna R; Cano E; Brea J; Raviña E
Bioorg Med Chem Lett; 2002 Jun; 12(12):1575-7. PubMed ID: 12039565
[TBL] [Abstract][Full Text] [Related]
16. [Studies on synthesis, anticonvulsant activity and the structure--activity relationships of 6-(substituted phenyl)-3 (2H) pyridazinones].
Xu P; Wang SY; Chen Y; Liu WQ; Tao C
Yao Xue Xue Bao; 1991; 26(9):656-60. PubMed ID: 1821084
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 6-[(4-imidazol-1-yl)-phenyl]-4-phenyl 4,5-dihydro-2H-pyridazin-3-one: a potential blood platelet aggregation inhibitor.
Coudert P; Rubat C; Couquelet J; Tronche P
J Pharm Belg; 1990; 45(3):191-5. PubMed ID: 2401951
[TBL] [Abstract][Full Text] [Related]
18. Isoxazolo-[3,4-d]-pyridazin-7-(6H)-one as a potential substrate for new aldose reductase inhibitors.
Costantino L; Rastelli G; Gamberini MC; Giovannoni MP; Dal Piaz V; Vianello P; Barlocco D
J Med Chem; 1999 Jun; 42(11):1894-900. PubMed ID: 10354397
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological evaluation of 5,6-dihydrobenzo[f] cinnolin-2(3H)ones analogues of antihypertensive and antiaggregating benzo[h]cinnolinones.
Pinna GA; Curzu MM; Fraghì P; Gavini E; D'Amico M
Farmaco; 1996 Oct; 51(10):653-8. PubMed ID: 8981755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
